IPOs 2024: Tempus AI Addresses Medical Diagnostic Use Case

According to a market report, the use of AI in medical diagnostics is expected to grow at 25% CAGR from $0.8 billion in 2022. Chicago-based Tempus AI (Nasdaq: TEM) is a leading player in the market that recently went public to a weak market response.

Featured Videos

1Mby1M Virtual Accelerator Investor Forum: With Julien Pham, 3CC Third Culture Capital (Part 5)

Sramana Mitra: So in that context, what companies have you invested in and what’s going on?

Julien Pham: Yeah. So for Fund One, we’ve invested in 15 companies so far. We’re probably going to invest in another two or three before we kind of wrap up the investment period for Fund One and start investing out of Fund Two. But out of the 15 companies we’ve invested in since 2021, 11 of them are squarely into digital health across different sectors or conditions like mental health and maternal health.

645th 1Mby1M Roundtable for Entrepreneurs Starting NOW: Live Tweeting by @1Mby1M

Today’s 645th FREE online 1Mby1M Roundtable for Entrepreneurs is starting NOW, on Thursday, July 11, at 8 a.m. PDT / 11 a.m. EDT / 5 p.m. CEST / 8:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!        

Video FAQs

645th Roundtable for Entrepreneurs Starting in 20 Minutes: Live Tweeting by @1Mby1M

Today’s 645th FREE online 1Mby1M Roundtable for Entrepreneurs is starting in 20 minutes, on Thursday, July 11, at 8 a.m. PDT / 11 a.m. EDT / 5 p.m. CEST / 8:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!

1Mby1M Virtual Accelerator Investor Forum: With Julien Pham, 3CC Third Culture Capital (Part 4)

Sramana Mitra: Exactly, and the other thing on your empathy question, the fundamental issue around AI is that why is it even necessary for us to replace all healthcare with AI? It’s really powerful. Where AI is really capable and powerful is in diagnostics and non-siloed diagnostics.

1Mby1M Virtual Accelerator Investor Forum: With Julien Pham, 3CC Third Culture Capital (Part 3)

Sramana Mitra: So let me comment on that. I would like to double click down on some of your companies, but on the broad level, I’m very bullish about education as well. I’m extremely bullish about healthcare, no question and AI in healthcare. But the trouble in education is that in the short to medium term, I think there is tremendous potential in education. Especially personalized tutoring is something I’m very, very excited and bullish about. Salman Khan is giving lots of talks about what he is doing with Khanmigo. I think personalized tutoring is an incredible opportunity.

AI Unicorns: Anthropic Focuses on Building a Safer AI Model

The rapid rise of generative AI technology has led to a growing concern around safety and security around the development of the technology. Backed by both Google and Amazon, Anthropic PBC is a public benefit company (PBC) that is focused on ensuring that they build systems that people can rely on and generate research about the opportunities and risks of AI.

1Mby1M Virtual Accelerator Investor Forum: With Julien Pham, 3CC Third Culture Capital (Part 2)

Sramana Mitra: So, now let’s talk about healthcare, specifically in the US. What kinds of opportunities are you zeroing in on with these investments? I would like to actually brainstorm a bit about the healthcare market in general, because as I’m sure you believe, I also believe that healthcare is one of the biggest opportunities of this next wave of technology – all the AI and everything. Every time you think about it, healthcare is one of the great unsolved problem that AI can really revolutionize.